Curium Resets FTC Clock On $8B Lantheus Take-Private Deal
Private equity-backed radiopharmaceutical company Curium reset the clock for the Federal Trade Commission's 30-day review of its plan to acquire fellow radiopharmaceutical company Lantheus Holdings Inc. in an $8 billion take-private deal....To view the full article, register now.
Already a subscriber? Click here to view full article